ATTD: Advanced Technologies and Treatments for Diabetes
ATTD: Advanced Technologies and Treatments for Diabetes
Podcast Description
ATTD is the ultimate forum to discover the latest diabetes research, devices, therapies and developments worldwide. This show, “ATTD Conference Catch-up”, will use AI podcasting to extract key insights from expert presentations and research discussions, transforming them into short, easy-to-digest episodes for busy healthcare professionals like you. So if you’re a diabetes specialist, researcher, or industry leader, this podcast is made for you.
Hit subscribe, and let’s explore the future of diabetes treatment, one breakthrough at a time.
Podcast Insights
Content Themes
The podcast focuses on the latest advancements in diabetes research and treatment, covering topics such as gene therapy, continuous glucose monitoring, and innovative technology applications in diabetes management, with specific episodes discussing beta cell therapies and the role of AI in diabetes care.
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals:
* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions.
* Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom).
Whether you’re a specialist, researcher, or industry leader, hit subscribe.
In this episode, we examine the concept of ”therapeutic inertia” in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation.
Key discussion points:
Defining therapeutic inertia in the context of insulin initiation.
Common clinician and patient-related barriers that contribute to treatment delays.
Practical strategies for introducing inhaled insulin to hesitant patients.
System-level considerations, including workflow and reimbursement challenges.
Find more resources and exclusive content on the ATTD Education Portal: https://unlok-education.com/attd/
Make sure to subscribe to the ATTD Diabetes Talks podcast for more insights and updates. Let’s advance diabetes care together.
#DiabetesCare #Endocrinology #InhaledInsulin #ATTD #MedicalPodcast
Chapters:
00:00 Why Inhaled Insulin Matters
00:34 Show Intro and Guest
01:22 Defining Therapeutic Inertia
02:19 Clinician Barriers to Insulin
03:49 Patient Fears and Hesitation
05:28 How Inhaled Insulin Helps
07:00 Best Fit Patient Scenarios
08:22 Talking to Hesitant Patients
10:39 Workflow and Coverage Hurdles
13:35 PFT Testing and Side Effects
14:47 Future Role and Wrap Up
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.